Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Canadian Journal of Physiology and Pharmacology
|
July 28, 2016
Synergistic in vitro antioxidant activity and observational clinical trial of F105, a phytochemical formulation including Citrus bergamia, in subjects with moderate cardiometabolic risk factors
John G Babish, Clinton J Dahlberg, Joseph J Ou, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 19, 2021
The Small Molecule BC-2059 Inhibits Wingless/Integrated (Wnt)-Dependent Gene Transcription in Cancer through Disruption of the Transducin <i>β</i>-Like 1-<i>β</i>-Catenin Protein Complex
Raffaella Soldi, Tithi Ghosh Halder, Samuel Sampson, et al.
Plos One
|
July 11, 2020
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer
Raffaella Soldi, Tithi Ghosh Halder, Alexis Weston, et al.
Nature
|
May 27, 2006
ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression
Xiaobing Shi, Tao Hong, Kay L Walter, et al.
Nature Communications
|
May 31, 2022
Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity
Sreya Biswas, Lauren N Rust, Jochen M Wettengel, et al.
Cancer Discovery
|
January 29, 2014
Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis
Tiffany J Parmenter, Margarete Kleinschmidt, Kathryn M Kinross, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Canadian Journal of Physiology and Pharmacology
|
July 28, 2016
Synergistic in vitro antioxidant activity and observational clinical trial of F105, a phytochemical formulation including Citrus bergamia, in subjects with moderate cardiometabolic risk factors
John G Babish, Clinton J Dahlberg, Joseph J Ou, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 19, 2021
The Small Molecule BC-2059 Inhibits Wingless/Integrated (Wnt)-Dependent Gene Transcription in Cancer through Disruption of the Transducin <i>β</i>-Like 1-<i>β</i>-Catenin Protein Complex
Raffaella Soldi, Tithi Ghosh Halder, Samuel Sampson, et al.
Plos One
|
July 11, 2020
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer
Raffaella Soldi, Tithi Ghosh Halder, Alexis Weston, et al.
Nature
|
May 27, 2006
ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression
Xiaobing Shi, Tao Hong, Kay L Walter, et al.
Nature Communications
|
May 31, 2022
Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity
Sreya Biswas, Lauren N Rust, Jochen M Wettengel, et al.
Cancer Discovery
|
January 29, 2014
Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis
Tiffany J Parmenter, Margarete Kleinschmidt, Kathryn M Kinross, et al.
Page
of 2